Sep 07, 2022 / 03:35PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this session with Medtronic. With us, we have Karen Parkhill, the CFO; and Greg Hertz from Investor Relations.
In terms of format, it's going to be a fireside chat. If anyone has a question they want me to ask on their behalf or if they want to ask, just raise your hand. So Karen, thanks so much for being here.
Karen L. Parkhill - Medtronic plc - EVP, CFO, IT & Enterprise Excellence
Thank you, Larry. .
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystSo Karen, we're starting all of these fireside chats off with the macro discussion, no surprise. You guys highlighted a number of macro headwinds on your fiscal Q1 call recently. Maybe just remind us of kind of what -- well, how do
Trustpilot
